Five-year review
for the year eneded 30 September 2016
| Rm | 2016 | Restated 2015 |
*# | 2014 | ** | Restated 2013 |
^** | 2012 | ** | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated income statements | ||||||||||||
| Revenue | 31 738 | 28 690 | 30 126 | 27 065 | 22 771 | |||||||
| Profit before taxation, income from associates, abnormal items and impairments | 3 978 | 3 823 | 3 155 | 2 721 | 3 356 | |||||||
| Income from associates | 861 | 603 | 597 | 515 | 416 | |||||||
| Abnormal items and impairments | (324) | (339) | (1 056) | (2) | 5 | |||||||
| Profit before taxation | 4 515 | 4 087 | 2 696 | 3 234 | 3 777 | |||||||
| Taxation | (1 221) | (977) | (832) | (837) | (1 029) | |||||||
| Profit for the year from continuing operations | 3 294 | 3 110 | 1 864 | 2 397 | 2 748 | |||||||
| Attributable to (continuing operations): | ||||||||||||
| Owners of the parent | 3 261 | 3 122 | 1 991 | 2 516 | 2 718 | |||||||
| Non-controlling interests | 33 | (12) | (127) | (119) | 30 | |||||||
| Consolidated statements of financial position | ||||||||||||
| Property, plant and equipment | 4 542 | 4 641 | 5 868 | 5 499 | 3 359 | |||||||
| Goodwill and intangible assets | 3 941 | 4 233 | 4 527 | 5 424 | 4 012 | |||||||
| Investments | 4 905 | 4 312 | 3 422 | 3 413 | 2 655 | |||||||
| Current assets | 11 099 | 11 617 | 10 728 | 9 486 | 7 783 | |||||||
| Assets classified as held for sale | – | – | – | 1 281 | – | |||||||
| Total assets | 24 487 | 24 803 | 24 545 | 25 103 | 17 809 | |||||||
| Issued capital and reserves before share-based payment reserve | 15 059 | 13 407 | 12 753 | 12 423 | 10 970 | |||||||
| Share-based payment reserve | 489 | 424 | 425 | 364 | 332 | |||||||
| Non-controlling interests | 487 | (53) | 770 | 1 028 | 393 | |||||||
| Deferred taxation liability/(asset) | 211 | 150 | (28) | 225 | 250 | |||||||
| Provision for post-retirement medical aid | 666 | 643 | 626 | 581 | 407 | |||||||
| Long-term borrowings | 1 069 | 1 215 | 627 | 1 453 | 235 | |||||||
| Current liabilities | 6 506 | 9 017 | 9 372 | 8 330 | 5 222 | |||||||
| Liabilities classified as held for sale | – | – | – | 699 | – | |||||||
| Total equity and liabilities | 24 487 | 24 803 | 24 545 | 25 103 | 17 809 | |||||||
| Consolidated cash flow statements | ||||||||||||
| Cash operating profit after interest and taxation | 3 432 | 2 841 | 3 168 | 2 915 | 3 048 | |||||||
| Working capital changes | (604) | (812) | (348) | (337) | (592) | |||||||
| Dividends received | 406 | 326 | 287 | 301 | 176 | |||||||
| Cash available from operations | 3 234 | 2 355 | 3 107 | 2 879 | 2 632 | |||||||
| Dividends and capital distributions paid | (1 661) | (1 643) | (1 467) | (1 426) | (1 318) | |||||||
| Net cash flow from operating activities | 1 573 | 712 | 1 640 | 1 453 | 1 314 | |||||||
| Net cash flow from investing activities | 115 | (1 056) | (415) | (3 282) | (732) | |||||||
| Net cash flow before financing activities | 1 688 | (344) | 1 225 | (1 829) | 582 | |||||||
| Net cash flow from financing activities | (562) | 76 | (1 109) | 426 | (297) | |||||||
| Net increase/(decrease) in cash and cash equivalents | 1 126 | (268) | 116 | (1 403) | 285 |
| * | The 2015 comparatives have been restated for the retrospective reclassification relating to the treatment of foreign exchange profits and losses on foreign cash and bank balances previously included in operating income/(loss) and now reclassified to net finance costs. Refer to annual financial statements for further details. |
| ** | Not restated for the exclusion of TBCG. |
| # | Income statement restated as required by IFRS 5 in relation to the treatment of Tiger Branded Consumer Goods plc (TBCG) as a discontinued operation. |
| ^ | The amounts have been restated due to the adoption of IAS 19R. |